oramed: optimization of radiation protection of medical … · oramed: optimization of radiation...
TRANSCRIPT
ORAMED: Optimization of Radiation Protection of Medical Staff
Dr. Ir. Filip Vanhavere
Belgian Nuclear Research Centre (SCK-CEN), Mol, Belgium
1°. SCK•CEN: Belgian Nuclear Research Centre, BelgiumF. Vanhavere, L. Struelens, S. Krim
2°. GAEC: Greek Atomic Energy Commission, Greece E. Carinou, C. Koukorava
3°. ENEA: Radiation Protection Institute, ItalyG. Gualdrini, P. Ferrari, F. Mariotti
4°. IRSN: Institut de Radioprotection et de Sûreté Nucléaire, FranceI. Clairand, L. Donadille, C. Itié, J. Debroas
5°. IRA: Institut Universitaire de Radiophysique Appliquée, SwitzerlandM. Sans, N. Ruiz, J.Mezzo, M. Tosic
6°. UPC: Universitat Politècnica de Catalunya, SpainM. Ginjaume, A. Carnicer, X. Ortega
7°. CEA-LIST: Laboratoire National Henri Becquerel, FranceJ.M.Bordy, J. Daures, M. Desnozière
8°. SMU: Slovak Medical University, Slovak RepublicD. Nikodemova, M. Fulop
9°. NIOM: Nofer Institute of Occupational Medicine, PolandJ. Jankowski, J. Domienik, M. Brodecki
10°. BfS: Federal Office of Radiation Protection, GermanyA. Rimpler, I. Barth
11°. Radcard, PolandS. Wach, P. Kocjan
12°. MGP Intruments (MGPi), FranceP. Martin, JL. Barrère
ORAMED: FP7 (02/2008-02/2011)
Objectives
Improve the knowledge on extremity and eye lens exposure in IR/IC and NM
Provide recommendations for optimization of working practices
Provide recommendations for optimization of the use of active personal dosemeters (APDs) in IR/IC
Develop training materials
Organization of ORAMED: 5 work packages
Extremity and eye lens dosimetry in IR/ICMain achievements1329 measurements (x 8 dosemeters) in 6 EU countries, > 40 hospitals/roomsTypes of procedures:
IC:CA/PTCA, RFA, PM/ICDIR:DSA/PTA LL, Re, Ca/Ce
EmbolizationERCP
Analysis of the parameters influencing the dosesRoom protective equipment – Tube configuration –Catheter access
Monte Carlo simulations
Recommendations
Study of the influence of each parameter separately
Main results
Personal protective equipment (lead apron, thyroid collar) are widely used, leaded glasses for ~30%.
No room protective equipment is used for ~25% of cases.
Large spread of doses are observed.
For IR and IC, embolization and PM/ICD lead to the highest doses, respectively.
Left wrist and finger are the positions with highest doses (closest to the scattering center). However, whenrespective annual limits are taken into account, the left eye position become more important.
Effect of the room protective equipmenton doses is smaller than (theoretically) expected.
Well designed and used room protective equipment are essential for a better protection.
Hand and eye doses are significantly higher for overcouch tube configurations (by 2-50 times) than forundercouch.
Hand and eye doses are higher for radial catheter access (by 2-7 times) than for femoral access.
Use of an automatic injector is associated with lower doses, by 4-16 times.
Extremity and eye lens dosimetry in IR/IC
Main results
Annual extrapolations:Frequency distribution for all procedures
(84 physicians)
Monitoring of the hands is recommended (especially for cardiology)
No need for leg monitoring if a table shield is properly used
Use of leaded glasses and monitoring of the eyes are recommended (except for ERCP)
New eye lens dose limit will be surpassed by many workers (near 50% ofcardiologists!)
Extremity and eye lens dosimetry in IR/IC
Eyes45-150
mSv; 8%
< 15mSv; 75%
15-45mSv; 17%
> 150mSv; 0%
Legs> 500
mSv; 1%
50-150mSv; 14%
< 50mSv; 81%
150-500mSv; 4%Wrists
150-500mSv; 6%
< 50mSv; 76%
50-150mSv; 18%
> 500mSv; 0%
Fingers150-500mSv; 2%
< 50mSv; 77%
50-150mSv; 17%
> 500mSv; 4%
Main achievements
Practical eye lens dosimetry in IR/IC
Proposal for eye lens dosemeter calibration and type testing for Hp(3)New phantom
Extensive calculations of conversion coefficients Hp(3)/Ka for photonsDesign and test of a dosemeter to measure Hp(3) (RADCARD)
Main achievements
8 commercially available APDs chosen
Use of active personal dosemeters in IR/IC
Tests:• in laboratory conditions, in continuous fields: dose, dose rate, energy and angular responses
• in laboratory conditions, in pulsed fields: dose rate, pulse frequency, pulse width
• at a medical X-ray facility (on phantom)
• in 7 European hospitals, in real conditions (102 measurements on operators, for 5 APDtypes out of 8)
Development of a prototype specifically designed for medical pulsed fields (MGPi)
Recommendations relating choice and use of APDs in IR/IC
ThermoEPD Mk2.3
Main results
In continuous X-ray beams: most APDs have correct behavior up to 10 Sv/h(according to IEC 61526 standard)
In pulsed X-ray beams: except for PM1621A, all APDs provide a reading.Limitations are mostly due to high dose rates rather than pulse frequency.
In hospital conditions: behavior more satisfactory than in laboratory conditions.Due to lower dose rates in the scattered field.
On operators: slight (by 20-30%) dose underestimation with respect to a passivedosemeter.
It is not recommended to use APDs as ‘legal dosimeters’ in IR/IC.
Use of active personal dosemeters in IR/IC
Extremity dosimetry in nuclear medicineMain achievements735 measurements (x 22 dosemeters) in 7 EU countries, 34 NM departments, for 124 workers99mTc, 18F, 90Y-Zevalin® (+ others)Preparation and administration stagesIdentification of good and bad practicesAnalysis of the parameters influencing the dosesMonte Carlo simulations (~200) for realistic scenarios (voxel phantoms)
Recommendations
99mTc preparationRange: 33 – 2062 µSv/GBqMean: 432 µSv/GBqN=36
18F administrationRange: 139 – 4113
µSv/GBqMean: 933 µSv/GBqN=30
18F administrationRange: 97 – 4433
µSv/GBqMean: 1205 µSv/GBqN=30
99mTc administrationRange: 12 – 951 µSv/GBqMean: 233 µSv/GBqN=32
Worker
Max
imum
Hp(
0.07
) [µ
Sv/G
Bq]
Main resultsLarge spread of doses is observed. Due to: practice, individual habit.
Bad practices are clearly associated with high doses, so are good practices with low doses.
Preparation leads to higher doses than administration.
Extremity dosimetry in nuclear medicine
18F preparation
Bad practices
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400
Maxim
um ann
ual dose (m
Sv)
Workers
Tc‐99m administration
Tc‐99m preparation
F‐18 administration
F‐18 preparation
Main results
Ratios between the maximum dose and dose at possible locations for routine monitoring
Good correlation are found between the maximum dose and doses at positions used for routinering dosemeters
Hand monitoring
Routine ring dosemeter shall be located at the base of the index finger of the non-dominant hand with the sensitive part of the dosemeter oriented towards the inside ofthe hand.For estimation of the maximum hand dose: multiply by 6
Extremity dosimetry in nuclear medicine
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400T6HB1
T9HB1
T2HF7
T3HF7
T6HD2
T7HD2
T3HD1
T1HD4
T10H
F2
T8HB1
T3HA2
T12H
F2
T3HE2
T3HD2
T2HD4
T11H
F2
T2HE2
T9HF2
T6HF7
T1HF7
T1HG4
T2HG4
T10H
E1T4HF2
T9HE1
T2HB1
T7HA2
T1HE3
T2HE3
T1HD3
T4HE2
T1HD2
T5HD2
T5HF7
T4HF7
T1HE3
T5HE1
T1HB1
T7HB1
T6HE1
T3HE3
T7HE1
T2HD2
T2HG5
T1HG5
T8HF2
T5HE2
T4HG2
T3HG2
T5HF2
T6HA2
T4HB3
T2HB3
T1HB3
T2HA2
T3HB3
T4HB1
T3HE1
T1HE1
T1HF3
T6HD1
T1HD1
T2HD1
T1HA1
T3HA1
T2HF4
T1HF4
Maxim
umannu
aldo
se(m
Sv)
2976
6994
9898
Annual dose estimationTc‐99m
ad
ministration
Tc‐99m
prep
aration
F‐18
ad
ministration
F‐18
prep
aration
D < 150 mSv 49%
150 mSv < D < 500 mSv 31%
D > 500 mSv 19%
More than
one
proced
ure
• Some workers were monitored for only one type of procedure forthe ORAMED project when actually they performed more. In thesecases, the estimation of the annual dose has been calculated onlyconsidering the monitored procedures, from which real measuredvalues were available.
ORAMED
Extensive dosimetric study on RP of medical staff, covering:
IR/IC and NM
Extremities, eye lens, whole-body
Measurements / MC simulations
Developments by manufacturers
Dissemination and training
ORAMED workshop, 20-21/01/2011, UPC, Barcelona, Spain
Training materials
Recommendations / guidelines: practical
> 20 publications + many presentations
Contacts with scientific organizations and networks, standard organizations…
Conclusions
Thank you for your attention!
Acknowledgment to the European Atomic Energy Community's Seventh Framework Programme for funding the ORAMED project under grant agreement n° 211361.
www.oramed-fp7.eu